515 related articles for article (PubMed ID: 15753396)
1. Role of glycogen synthase kinase 3beta in rapamycin-mediated cell cycle regulation and chemosensitivity.
Dong J; Peng J; Zhang H; Mondesire WH; Jian W; Mills GB; Hung MC; Meric-Bernstam F
Cancer Res; 2005 Mar; 65(5):1961-72. PubMed ID: 15753396
[TBL] [Abstract][Full Text] [Related]
2. Dictyostelium differentiation-inducing factor-3 activates glycogen synthase kinase-3beta and degrades cyclin D1 in mammalian cells.
Takahashi-Yanaga F; Taba Y; Miwa Y; Kubohara Y; Watanabe Y; Hirata M; Morimoto S; Sasaguri T
J Biol Chem; 2003 Mar; 278(11):9663-70. PubMed ID: 12522140
[TBL] [Abstract][Full Text] [Related]
3. Cyclin D3 is down-regulated by rapamycin in HER-2-overexpressing breast cancer cells.
García-Morales P; Hernando E; Carrasco-García E; Menéndez-Gutierrez MP; Saceda M; Martínez-Lacaci I
Mol Cancer Ther; 2006 Sep; 5(9):2172-81. PubMed ID: 16985050
[TBL] [Abstract][Full Text] [Related]
4. Proteasome-dependent degradation of cyclin D1 in 1-methyl-4-phenylpyridinium ion (MPP+)-induced cell cycle arrest.
Bai J; Nakamura H; Ueda S; Kwon YW; Tanaka T; Ban S; Yodoi J
J Biol Chem; 2004 Sep; 279(37):38710-4. PubMed ID: 15247282
[TBL] [Abstract][Full Text] [Related]
5. Anticancer activity of protocatechualdehyde in human breast cancer cells.
Choi J; Jiang X; Jeong JB; Lee SH
J Med Food; 2014 Aug; 17(8):842-8. PubMed ID: 24712725
[TBL] [Abstract][Full Text] [Related]
6. Proteasome inhibition-induced p38 MAPK/ERK signaling regulates autophagy and apoptosis through the dual phosphorylation of glycogen synthase kinase 3β.
Choi CH; Lee BH; Ahn SG; Oh SH
Biochem Biophys Res Commun; 2012 Feb; 418(4):759-64. PubMed ID: 22310719
[TBL] [Abstract][Full Text] [Related]
7. Glycogen synthase kinase 3 has a limited role in cell cycle regulation of cyclin D1 levels.
Yang K; Guo Y; Stacey WC; Harwalkar J; Fretthold J; Hitomi M; Stacey DW
BMC Cell Biol; 2006 Aug; 7():33. PubMed ID: 16942622
[TBL] [Abstract][Full Text] [Related]
8. CG0009, a novel glycogen synthase kinase 3 inhibitor, induces cell death through cyclin D1 depletion in breast cancer cells.
Kim HM; Kim CS; Lee JH; Jang SJ; Hwang JJ; Ro S; Choi J
PLoS One; 2013; 8(4):e60383. PubMed ID: 23565238
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase inhibitor, trichostatin A induces ubiquitin-dependent cyclin D1 degradation in MCF-7 breast cancer cells.
Alao JP; Stavropoulou AV; Lam EW; Coombes RC; Vigushin DM
Mol Cancer; 2006 Feb; 5():8. PubMed ID: 16504004
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of glycogen synthase kinase-3beta, a downstream target of the raf-1 pathway, is associated with growth suppression in medullary thyroid cancer cells.
Kunnimalaiyaan M; Vaccaro AM; Ndiaye MA; Chen H
Mol Cancer Ther; 2007 Mar; 6(3):1151-8. PubMed ID: 17363508
[TBL] [Abstract][Full Text] [Related]
11. GSK3 is required for rapalogs to induce degradation of some oncogenic proteins and to suppress cancer cell growth.
Koo J; Wang X; Owonikoko TK; Ramalingam SS; Khuri FR; Sun SY
Oncotarget; 2015 Apr; 6(11):8974-87. PubMed ID: 25797247
[TBL] [Abstract][Full Text] [Related]
12. Advanced glycation end-product-inhibited cell proliferation and protein expression of beta-catenin and cyclin D1 are dependent on glycogen synthase kinase 3beta in LLC-PK1 cells.
Lin KH; Guh JY; Mo JF; Chiou SJ; Hwang CC; Chuang LY
Arch Biochem Biophys; 2008 Sep; 477(1):27-32. PubMed ID: 18474214
[TBL] [Abstract][Full Text] [Related]
13. Regulation of Akt mRNA and protein levels by glycogen synthase kinase-3beta in adrenal chromaffin cells: effects of LiCl and SB216763.
Nemoto T; Kanai T; Yanagita T; Satoh S; Maruta T; Yoshikawa N; Kobayashi H; Wada A
Eur J Pharmacol; 2008 May; 586(1-3):82-9. PubMed ID: 18395711
[TBL] [Abstract][Full Text] [Related]
14. Differentiation-inducing factor-1 induces cyclin D1 degradation through the phosphorylation of Thr286 in squamous cell carcinoma.
Mori J; Takahashi-Yanaga F; Miwa Y; Watanabe Y; Hirata M; Morimoto S; Shirasuna K; Sasaguri T
Exp Cell Res; 2005 Nov; 310(2):426-33. PubMed ID: 16153639
[TBL] [Abstract][Full Text] [Related]
15. [Effects of glycogen synthase kinase 3β overexpression in rat and glycogen synthase kinase 3β inhibitor SB-216763 on proliferation of hepatic oval cells].
Zhong JQ; Xie YK; Ji XK; Fu JH; Wang Y; Zhang QY; Shi HQ; Shan YF
Zhonghua Wai Ke Za Zhi; 2012 Nov; 50(11):1003-6. PubMed ID: 23302485
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitin-dependent proteolysis of cyclin D1 is associated with coxsackievirus-induced cell growth arrest.
Luo H; Zhang J; Dastvan F; Yanagawa B; Reidy MA; Zhang HM; Yang D; Wilson JE; McManus BM
J Virol; 2003 Jan; 77(1):1-9. PubMed ID: 12477805
[TBL] [Abstract][Full Text] [Related]
17. Rapamycin inhibition of the G1 to S transition is mediated by effects on cyclin D1 mRNA and protein stability.
Hashemolhosseini S; Nagamine Y; Morley SJ; Desrivières S; Mercep L; Ferrari S
J Biol Chem; 1998 Jun; 273(23):14424-9. PubMed ID: 9603954
[TBL] [Abstract][Full Text] [Related]
18. Glycogen synthase kinase 3beta induces cell cycle arrest in a cyclin D1-dependent manner in human lung adenocarcinoma cell line A549.
Li JS; Zhu M; Tian D; Wang MX; Wang F; Li NP; Wu RL
Sheng Li Xue Bao; 2007 Apr; 59(2):204-9. PubMed ID: 17437044
[TBL] [Abstract][Full Text] [Related]
19. Activation of p53-dependent apoptosis by acute ablation of glycogen synthase kinase-3beta in colorectal cancer cells.
Ghosh JC; Altieri DC
Clin Cancer Res; 2005 Jun; 11(12):4580-8. PubMed ID: 15958644
[TBL] [Abstract][Full Text] [Related]
20. Luteolin induces G1 arrest in human nasopharyngeal carcinoma cells via the Akt-GSK-3β-Cyclin D1 pathway.
Ong CS; Zhou J; Ong CN; Shen HM
Cancer Lett; 2010 Dec; 298(2):167-75. PubMed ID: 20655656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]